|
FAM18B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.994450E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.396600E-03 |
| Normal-vs-Stage2 |
9.794100E-02 |
| Normal-vs-Stage3 |
2.09719999999525E-05 |
| Normal-vs-Stage4 |
1.648940E-04 |
| Stage1-vs-Stage2 |
9.615200E-01 |
| Stage1-vs-Stage3 |
9.399200E-03 |
| Stage1-vs-Stage4 |
5.368000E-02 |
| Stage2-vs-Stage3 |
1.574240E-01 |
| Stage2-vs-Stage4 |
2.811400E-01 |
| Stage3-vs-Stage4 |
6.443800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.416900E-04 |
| Normal-vs-AfricanAmerican |
4.640100E-04 |
| Normal-vs-Asian |
6.183200E-01 |
| Caucasian-vs-AfricanAmerican |
4.336000E-01 |
| Caucasian-vs-Asian |
4.252200E-01 |
| AfricanAmerican-vs-Asian |
2.120800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.58459999999905E-05 |
| Normal-vs-Female |
6.537200E-03 |
| Male-vs-Female |
5.635600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.216300E-03 |
| Normal-vs-Age(41-60Yrs) |
1.976490E-03 |
| Normal-vs-Age(61-80Yrs) |
3.434900E-04 |
| Normal-vs-Age(81-100Yrs) |
3.020600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.744600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.456000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.215200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.653600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.523800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.209800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.148400E-01 |
| Normal-vs-Grade 2 |
3.401800E-02 |
| Normal-vs-Grade 3 |
1.57649999998899E-06 |
| Normal-vs-Grade 4 |
4.29300000004407E-06 |
| Grade 1-vs-Grade 2 |
4.835200E-01 |
| Grade 1-vs-Grade 3 |
4.361900E-02 |
| Grade 1-vs-Grade 4 |
2.321700E-02 |
| Grade 2-vs-Grade 3 |
2.679700E-03 |
| Grade 2-vs-Grade 4 |
2.543800E-03 |
| Grade 3-vs-Grade 4 |
2.509000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.115200E-01 |
| Normal-vs-ccB subtype |
3.86100000004941E-06 |
| ccA subtype-vs-ccB subtype |
1.5693799999994E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.635300E-03 |
| Normal-vs-N1 |
2.386800E-01 |
| N0-vs-N1 |
6.822200E-01 |
|
|
